Abstract |
Androgen deprivation therapy is initially effective for treating patients with advanced prostate cancer; however, the prostate cancer gradually becomes resistant to androgen deprivation therapy, which is termed castration-resistant prostate cancer (CRPC). Androgen receptor splice variant 7 (AR-V7), one of the causes of CRPC, is correlated with resistance to a new-generation AR antagonist ( enzalutamide) and poor prognosis. Heat shock protein 70 (Hsp70) inhibitor is known to decrease the levels of full-length AR (AR-FL), but little is known about its effects against CRPC cells expressing AR-V7. In this study, we investigated the effect of the Hsp70 inhibitors quercetin and VER155008 in the prostate cancer cell line LNCaP95 that expresses AR-V7, and explored the mechanism by which Hsp70 regulates AR-FL and AR-V7 expression. Quercetin and VER155008 decreased cell proliferation, increased the proportion of apoptotic cells, and decreased the protein levels of AR-FL and AR-V7. Furthermore, VER155008 decreased AR-FL and AR-V7 mRNA levels. Immunoprecipitation with Hsp70 antibody and mass spectrometry identified Y-box binding protein 1 (YB-1) as one of the molecules regulating AR-FL and AR-V7 at the transcription level through interaction with Hsp70. VER155008 decreased the phosphorylation of YB-1 and its localization in the nucleus, indicating that the involvement of Hsp70 in AR regulation might be mediated through the activation and nuclear translocation of YB-1. Collectively, these results suggest that Hsp70 inhibitors have potential anti- tumor activity against CRPC by decreasing AR-FL and AR-V7 expression through YB-1 suppression.
|
Authors | Kazuaki Kita, Masayuki Shiota, Masako Tanaka, Asuka Otsuka, Masaki Matsumoto, Minoru Kato, Satoshi Tamada, Hiroshi Iwao, Katsuyuki Miura, Tatsuya Nakatani, Shuhei Tomita |
Journal | Cancer science
(Cancer Sci)
Vol. 108
Issue 9
Pg. 1820-1827
(Sep 2017)
ISSN: 1349-7006 [Electronic] England |
PMID | 28691182
(Publication Type: Journal Article)
|
Copyright | © 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. |
Chemical References |
- Antineoplastic Agents, Hormonal
- HSP70 Heat-Shock Proteins
- Purine Nucleosides
- Receptors, Androgen
- VER 155008
- Y-Box-Binding Protein 1
- YBX1 protein, human
- Quercetin
|
Topics |
- Antineoplastic Agents, Hormonal
(pharmacology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Gene Expression
(drug effects)
- Gene Silencing
(drug effects)
- HSP70 Heat-Shock Proteins
(antagonists & inhibitors, metabolism)
- Humans
- Male
- Prostatic Neoplasms
(drug therapy, metabolism)
- Purine Nucleosides
(pharmacology)
- Quercetin
(pharmacology)
- Receptors, Androgen
(genetics, metabolism)
- Y-Box-Binding Protein 1
(metabolism)
|